Predictive value of serum uric acid on cardiovascular disease and all-cause mortality in urban Chinese patients

Chinese Medical Journal

Volumn 123, Issue 11, 2010, Pages 1387-1391

  Wu, Yong quan ^a   Li, Jue ^b   Xu, Yuan xi ^c   Wang, Yong liang ^a   Luo, Ying yi ^c   Hu, Da yi ^c   Liu, Wei jing ^d   Yang, Ming ^e   Pi, Lin ^f   Wang, Ming sheng ^g   Wang, Ji yun ^g   Zhao, Shu mei ^a   Li, Mei jing ^h  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

^c TONGJI HOSPITAL OF TONGJI UNIVERSITY   (China)

^d TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

^e CAPITAL MEDICAL UNIVERSITY   (China)

^f BEIJING CHUIYANGLIU HOSPITAL   (China)

^g CAPITAL MEDICAL UNIVERSITY   (China)

^h Key Laboratory of Arrhythmias of Ministry of Education   (China)

Author keywords

Cardiovascular disease; Mortality; Serum uric acid

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHINESE; CHOLESTEROL BLOOD LEVEL; DIAGNOSTIC VALUE; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; URBAN AREA; URIC ACID BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; URIC ACID;

EID: 77953505974     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.11.006     Document Type: Article

References (26)

1. Niskanen LK, Laaksonen DE, Nyyssonen K, Alfthan G, Lakka HM, Lakka TA, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men. Arch Intern Med 2004; 164: 1546-1551.
2. Wang JG, Staessen JA, Fagard RH, Birkenhäger WH, Gong L, Liu L. Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension. Hypertension 2001; 37: 1069-1074.
3. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999; 131: 7-13.
4. Tuttle KR, Short RA, Johnson RJ. Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol 2001; 87: 1411-1414.
5. Vigna GB, Bolzan M, Romagnoni F, Valerio G, Vitale E, Zuliani G, et al. Lipid and other risk factors selected by discriminant analysis in symptomatic patients with supra-aortic and peripheral atherosclerosis. Circulation 1992; 85: 2205-2211.
6. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality: the NHANESI epidemiologic follow-up study, 1971-1992. JAMA 2000; 283: 2404-2410.
7. Cannon PJ, Stason WB, Demartini FE. Hyperuremia in primary and renal hypertention. N Engl J Med 1966; 275: 457-464.
8. Gertler MM, Garn SM, Levine SA. Serum uric acid in relation to age and physique in health and in coronary heart disease. Ann Intern Med 1951; 34: 1421-1431.
9. Lehto S, Niskanen L, Ronnemaa T, Laakso M. Serum uric acid is strong predictor of stroke in patients with noninsulin-dependent diabetes mellitus. Stroke 1998; 29: 635-639.
10. Niskanen LK, Laaksonen DE, Nyyssönen K, Alfthan G, Lakka HM, Lakka TA, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004; 164: 1546-1551.
11. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999; 131: 7-13.
12. Alderman MH, Cohen H, Madhavan S, Kivlighn S. Serumn uric acid and cardiovascular events in successfully treated hypertensive patiens. Hypertension 1999; 34: 144-150.
13. Niskanen L, Laaksonen DE, Lindström J, Eriksson JG, Keinänen-Kiukaanniemi S, Ilanne-Parikka P, et al. Serum uric as a harbinger of metabolic outcome in subjects with impaired glucose tolerance: the Finish Diabetes Prevention Study. Diabetes Care 2006; 29: 709-711.
14. Alper AB Jr, Chen W, Yau L, Srinivasan SR, Berenson GS, Hamm LL. Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study. Hypertention 2005; 45: 34-38.
15. Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML. Serum uric acid and plasma norepinepherine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003; 42: 474-480.
16. Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of hyperuremia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 2004; 44: 642-650.
17. Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K. Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol 2003; 18: 523-530.
18. Siu YP, Leung KT, Tong MK, Kwan TH. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 2006; 47: 51-59.
19. Kanbay M, Ozkara A, Selcoki Y. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatine clearence, and protenuria in patients with normal renal functions. Int Urol Nephrol 2007; 39: 1227-1233.
20. Milionis HJ, Kalantzi KJ, Goudevenos JA, Seferiadis K, Mikhailidis DP, Elisaf MS. Serum uric acid levels and risk for acute ischaemic non-embolic stroke in edlerly subjects. J Intern Med 2005; 258: 435-441.
21. Daskalopoulou SS, Athyros VG, Elisaf M, Mikhailidis D. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int 2004; 66: 1714-1715.
22. Weir CJ, Muir SW, Walters MR, Lees KR. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 2003; 34: 1951-1956.
23. Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003; 42: 474-480.
24. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998; 2: 275-281.
25. Waring WS, Webb DJ, Maxwell SRJ. Effect of local hyperuricaemia on endothelial function in the human forearm vascular bed. Br J Clin Pharmacol 2000; 49: 511P.
26. Nakanishi N, Shiraishi T, Wada M. C-reactive protein concentration is more strongly related to metabolic syndrome in women than in men: the Minoh Study. Circ J 2005; 69: 386-391.